UCP1 and obesity disorder: Oral supplementation could affect the signals associated with lipid catabolism, lipolysis, mitochondria biogenesis, and uncoupling protein 1 (UCP1)-positive cells in the adipose tissues and contribute to managing obesity and metabolic syndrome [18].